Inclacumab

DB12246InvestigationalProtein Based Therapies

Inclacumab has been used in trials studying the treatment and prevention of Myocardial Infarction, Peripheral Arterial Disease (PAD), and Coronary Heart Disease, Graft Occlusion, Vascular.

Mechanism: Pharmacologically active on P-selectin
Curator reviewed
Code names: RG-1512 · RO4905417

Resolves to

Compound

UNIIA6734I702LCAS1256258-86-2

Targets

P16109SELP

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

7Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Inclacumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account